| Image |
|
| GO Annotations |
Cellular Component |
|
| Molecular Function |
|
| Biological Process |
|
| Pathways |
|
| Drugs |
|
| Diseases |
|
| GWAS |
- 3-month functional outcome in ischaemic stroke (modified Rankin score) ( 30796134)
- Adverse response to drug ( 30420678)
- Alanine aminotransferase levels ( 33547301)
- Cadmium levels ( 26025379)
- Daytime sleep phenotypes ( 27126917)
- High chromosomal aberration frequency (chromatid type) in genotoxic compound exposure ( 31586183)
- Hip circumference ( 28552196)
- Hip circumference adjusted for BMI ( 28552196)
- Neuritic plaque ( 31497858)
- Obesity-related traits ( 23251661)
- Plasma factor V levels in venous thrombosis (conditioned on rs6027) ( 31271701)
- Plasma parathyroid hormone levels ( 30134803)
- Pulmonary function (FVC) x omega-3 PUFA (docosahexaenoic acid) interaction (2df) ( 30199657)
- Response to antidepressants in depression ( 27622933)
- Severe influenza A (H1N1) infection ( 26379185)
- Stress sensitivity (neuroticism score x major depressive disorder status interaction) ( 30571770)
- Suicide attempts in major depressive disorder ( 26079190)
- Survival in colon cancer ( 25866641)
- Survival in microsatellite instability low/stable colorectal cancer ( 25866641)
- Systolic blood pressure in sickle cell anemia ( 24058526)
- Urate levels (BMI interaction) ( 25811787)
|
| Interacting Genes |
1 interacting genes:
KCND2
|
| Entrez ID |
57628 |
| HPRD ID |
07083 |
| Ensembl ID |
ENSG00000175497
|
| Uniprot IDs |
B2RCJ8
B4DKB5
Q0GLB7
Q0GLB9
Q8N608
|
| PDB IDs |
4WJL
|
| Enriched GO Terms of Interacting Partners? |
|
| Tagcloud ? |
|